9P6-15447-26690
4 vaccinations
3 coded responses
17 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 16-20
- ZIP prefix
- 335 / FL
- Registered
- 2022-01-30
- Relationship
- Child or adolescent in my care
- Guardian
- 6VW-32828-71539
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-14
Dose 1 — Pfizer-BioNTech
-
2021-05-05
Dose 2 — Pfizer-BioNTech
-
2022-01-29
Dose 3 — Pfizer-BioNTech
-
2022-01-30
Registered in v-safe
-
2022-01-31
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Dizziness — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend schoolFree text: LightheadednessMedDRA releases: 2024-11 · check-in free text available
-
2022-02-01
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Fatigue or tirednessAdult check-in
-
2022-02-02
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2022-02-03
- 2022-02-04
- 2022-02-05
- 2022-02-12
- 2022-02-19
- 2022-03-05
- 2022-03-12
-
2022-04-30
Survey response — 3 months, dose 3, dependentMedDRA: Myalgia — Feeling: Fair · Be unable to work or attend schoolFree text: Muscle aches and painsMedDRA releases: 2024-11 · check-in free text available
- 2022-07-30
-
2022-09-22
Dose 4 — Pfizer-BioNTech
- 2022-10-23
- 2022-10-27
-
2022-11-03
Survey response — day 42, dose 4, dependentMedDRA: Fatigue — Feeling: FairFree text: Severe fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-12-22
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Pfizer-BioNTech | No |
| 2 | 2021-05-05 | Pfizer-BioNTech | No |
| 3 | 2022-01-29 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Lightheadedness
Release 11 — 3 months, dose 3, dependent
Symptoms: Muscle aches and pains
Release 12 — day 42, dose 4, dependent
Symptoms: Severe fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release